References
- Miyamoto S, Kawana H, Sakamoto T, Soejima H, Kajiwara I, Shimomura H et al. Formation of platelet microaggregates correlates with adverse clinical outcome in patients with coronary artery disease. Thromb Haemost 2003; 89: 681–6.
- Michelson A D, Barnard M R, Kruger L A, Valeri C R, Furman M I. Circulating monocyte-platelet aggregated are a more sensitive marker of in vivo platelet activation than platelet P-selectin: studies in baboons, human coronary intervention, and human myocardial infarction. Circulation 2001; 104: 1533–7.
- Garlichs C D, Eskafi S, Raaz D, Schmidt A, Ludwig J, Herrman M et al. Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets. Heart 2001; 86: 649–55.
- Chakhtoura E Y, Shamoon F E, Haft J I, Obiedzinski G R, Cohen A J, Watson R M. Comparison of platelet activation in unstable and stable angina pectoris and correlation with coronary angiographic findings. Am J Cardiol 2000; 86: 835–9.
- Chirkov Y Y, Holmes A S, Chirkova L P, Horowitz J D. Nitrate resistance in platelets from patients with stable angina pectoris. Circulation 1999; 100: 129–34.
- Sogo N, Magid K S, Shaw C A, Webb D J, Megson I L. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mecha-nisms. Biochem Biophys Res Commun 2000; 279: 412–9.
- Broadley A J M, Gapper P, Schmitt M, Frenneaux M P. Supine rest reduces platelet activation and aggregation. Platelets 2003; 14: 3–7.
- Chirkov Y Y, Holmes A S, Willoughby S R, Stewart S, Wuttke R D, Sage P R, Horowitz J D. Stable angina and acute coronary syndromes are associated with nitric oxide resistance in platelets. J Am Coll Cardiol 2001; 37: 1851–7.
- Ellis G R, Anderson R A, Chirkov Y Y, Morris-Thurgood J, Jackson S K, Lewis M J et al. Acute effects of vitamin C on platelet responsiveness to nitric oxide donors and endothelial function in patients with chronic heart failure. J Cardiovasc Pharmacol 2001; 37: 564–70.